V

    Vivani Medical Inc. (VANI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.39
    -0.03 (-2.11%)

    Market Cap: $128.09M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(22/34)
    Avg Surprise
    +8.46%
    Streak
    4 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.09
    Range$-0.09 - $-0.09
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.09+0.0%
    60d ago$-0.09+0.0%
    30d ago$-0.08+7.4%
    7d ago$-0.08+7.4%
    Current$-0.09
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.08
    Range$-0.08 - $-0.08
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.08---
    Sep 26EST
    		-$-0.09---
    Jun 26
    		$-0.07$-0.08+12.50%Beat+41.7%
    Mar 26
    		$-0.08$-0.08+0.00%Beat+24.1%
    Dec 25
    		$-0.09$-0.10+5.26%Beat+18.2%
    Sep 25
    		$-0.11$-0.11+0.00%Beat+0.0%
    Jun 25
    		$-0.12$-0.10-20.00%Miss-20.0%
    Mar 25
    		$-0.11$-0.12+12.17%Beat+12.2%
    Dec 24
    		$-0.11$-0.11+0.00%Beat+8.3%
    Sep 24
    		$-0.11$-0.10-10.00%Miss+15.4%
    Jun 24
    		$-0.10$-0.12+16.67%Beat+23.1%
    Mar 24
    		$-0.12$-0.12+0.00%Beat+0.0%
    Dec 23
    		$-0.12$-0.14+14.29%Beat+33.3%
    Sep 23
    		$-0.13$-0.13+0.00%Beat-451.4%
    Jun 23
    		$-0.13$-0.11-18.18%Miss-62.5%
    Mar 23
    		$-0.12$-0.12+0.00%Beat-100.0%
    Dec 22
    		$-0.18$0.00N/AMiss-200.0%
    Sep 22
    		$0.04$0.00N/ABeat+161.7%
    Jun 22
    		$-0.08N/AN/ABeat-33.3%
    Mar 22
    		$-0.06N/AN/ABeat+0.0%
    Dec 21
    		$-0.06$-0.04-50.00%Miss+0.0%
    Sep 21
    		$-0.06N/A+82.86%Beat+71.4%
    Jun 21
    		$-0.06N/A+82.86%Beat+86.7%
    Mar 21
    		$-0.06N/A+86.36%Beat+96.5%
    Dec 20
    		$-0.06N/A+85.71%Beat+96.0%
    Sep 20
    		$-0.21$-0.41+48.78%Beat+85.4%
    Jun 20
    		$-0.45N/A+63.41%Beat+73.2%
    Mar 20
    		$-1.71$-1.23-39.02%Miss+10.9%
    Dec 19
    		$-1.50$-1.47-2.04%Miss+47.9%
    Sep 19
    		$-1.44$-1.44+0.00%Beat+50.0%
    Jun 19
    		$-1.68$-1.44-16.67%Miss+41.7%
    Mar 19
    		$-1.92$-1.44-33.33%Miss-71.4%
    Dec 18
    		$-2.88$-2.64-9.09%Miss+7.7%
    Sep 18
    		$-2.88$-3.36+14.29%Beat-227.3%
    Jun 18
    		$-2.88$-3.36+14.29%Beat+0.0%
    Mar 18
    		$-1.12N/AN/ABeat+70.8%
    Dec 17
    		$-3.12$-3.36+7.14%Beat+45.8%
    Sep 17
    		$-0.88N/AN/ABeat+81.7%
    Jun 17
    		$-2.88$-3.60+20.00%Beat-
    Mar 17
    		$-3.84$-3.36-14.29%Miss-
    Dec 16
    		$-5.76$-4.08-41.18%Miss-
    Sep 16
    		$-4.80$-3.84-25.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-3.97EV/EBITDA-3.93x
    Price/FCF-4.57xFCF Yield-21.89%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-220.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio3.25xQuick Ratio3.25x
    Trading Statistics
    Beta3.28Avg Volume184.79K
    52-Week High$1.9252-Week Low$0.92

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.41
    SMA 20$1.39
    SMA 50$1.35
    SMA 200$1.28
    EMA 10$1.40
    EMA 20$1.39
    EMA 50$1.35
    EMA 200$1.29

    MACD

    Line: 0.02Signal: 0.02Hist: -0.00

    ADX

    ADX: 26.0+DI: 23.1-DI: 8.6

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down4.0
    PSAR$1.50

    Bollinger Bands

    Upper Band$1.45
    Lower Band$1.34
    %B Position751%(Upper)
    Band Width0.47

    RSI (14-Day)

    Neutral
    51.4

    Momentum Oscillators

    Stoch %K44.7
    Stoch %D47.1
    Williams %R-61.1
    ROC (10d)3.0%
    Momentum0.04
    CCI (20d)99.3
    MFI (14d)35.1

    Volatility Measures

    ATR (14d)$0.08(5.9%)
    StdDev (20d)0.03
    Hist Vol48.9%(High)

    Volume Flow

    VWAP$1.41
    OBV23.7M
    AD Line2.5M
    CMF (20d)0.049

    Volume Metrics

    Avg Vol (20d)186.7K
    Vol Ratio1.1x
    VWMA (20d)$1.40

    Pivot Points

    R3$1.48
    R2$1.45
    R1$1.44
    Pivot Point$1.41
    S1$1.40
    S2$1.37
    S3$1.36

    Advanced Oscillators

    TSI6.66
    Ultimate Osc49.3
    KST42.40

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$398,000$0$0$0$518,000$0
    Cost of Revenue$0$0$115,000$0$0$0$89,000$0$0$0$98,000$0
    Gross Profit$0$0$-115,000$0$0$0$-89,000$0$0$0$-98,000$0
    Operating Expenses$6.87M$6.78M$6.81M$6.72M$7.46M$6.56M$6.46M$6.31M$5.68M$6.23M$6.22M$7.14M
    R&D$4.46M$4.39M$4.63M$4.52M$4.76M$4.22M$4.30M$4.20M$3.51M$3.73M$4.71M$4.44M
    SG&A$2.42M$2.43M$2.18M$2.21M$2.70M$2.34M$2.16M$2.11M$2.17M$2.50M$1.51M$2.70M
    Operating Income$-6,874,000$-6,817,000$-6,812,000$-6,725,000$-7,462,000$-6,557,000$-6,460,000$-6,309,000$-5,681,000$-6,227,000$-6,217,000$-7,144,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-6,370,000$-6,817,000$-5,865,000$-6,725,000$-7,462,000$-6,302,000$-5,457,000$-6,309,000$-5,681,000$-6,039,000$-6,217,000$-7,144,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,370,000$-6,780,000$-6,633,000$-6,530,000$-7,144,000$-6,302,000$-6,050,000$-6,041,000$-5,356,000$-6,039,000$-6,026,000$-6,782,000
    EBITDA$-6,242,000$-6,687,000$-6,697,000$-6,620,000$-7,360,000$-6,200,000$-6,371,000$-6,197,000$-5,508,000$-5,858,000$-6,044,000$-6,372,000
    EBIT$-6,370,000$-6,817,000$-6,812,000$-6,725,000$-7,462,000$-6,302,000$-6,460,000$-6,309,000$-5,681,000$-6,039,000$-6,217,000$-7,144,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VANI

    News

    Form 8K Vivani Medical Inc For: 17 August By Investing.com

    This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 17th. The brief notice highlights the immediate disclosure of this financial document.

    Investing.com Nigeria•8/18/26•
    Neutral

    Vivani Medical posts investor deck outlining NanoPortal ultra-long-acting GLP-1 implant strategy for obesity market

    Vivani Medical has released an investor deck detailing its NanoPortal ultra-long-acting subdermal GLP-1 implant platform, aiming for once- or twice-yearly dosing for chronic weight management. Their lead candidate, NPM-139 (a semaglutide implant), is in the SLIM-1 study with top-line data expected in November 2026, and a Phase 2 study is planned for 2027. The company's cash runway is projected to last through the first half of 2027, covering key milestones, while noting the significant 2025 global sales of FDA-approved GLP-1 products and their high discontinuation rates.

    Bitget•8/17/26•
    Somewhat-Bullish

    Form 8K Vivani Medical Inc For: 17 August By Investing.com

    This article reports on Vivani Medical Inc.'s Form 8K filing for August 17th. The brief news item includes the company's stock symbol (VANI) and its current performance (-3.57%). The article is presented by Investing.com.

    Investing.com Canada•8/17/26•
    Neutral

    Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached

    Vivani Medical has filed an 8-K report, attaching a slide presentation as Exhibit 99.1. This presentation was distributed to the investment community and at conferences, providing key information about the company. The company notes that the presentation reflects information only as of the filing date and disclaims any obligation to update it.

    TradingView•8/17/26•
    Neutral

    Form 8K Vivani Medical Inc For: 17 August By Investing.com

    This article reports on the filing of a Form 8K by Vivani Medical Inc. for August 17th. The brief news item from Investing.com indicates this as a significant regulatory disclosure for the company, stock symbol VANI.

    Investing.com India•8/17/26•
    Somewhat-Bearish

    Frequently Asked Questions About VANI

    Does VANI pay dividends?
    Vivani Medical Inc. (VANI) does not currently pay a regular dividend.
    What is VANI's market cap?
    Vivani Medical Inc. (VANI) has a market capitalization of $128.09M with a current stock price of $1.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In